Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MDVN > SEC Filings for MDVN > Form 8-K on 1-Jul-2014All Recent SEC Filings

Show all filings for MEDIVATION, INC.

Form 8-K for MEDIVATION, INC.


1-Jul-2014

Change in Directors or Principal Officers, Submission of Matters to a Vote of Se


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Approval of the Amended and Restated 2004 Equity Incentive Award Plan

The annual meeting of stockholders of Medivation, Inc. was held on June 27, 2014 (the "Annual Meeting"). At the Annual Meeting, the stockholders of Medivation approved the Medivation, Inc. Amended and Restated 2004 Equity Incentive Award Plan (the "2004 Plan") to (a) increase the aggregate number of shares of common stock authorized for issuance under the Amended 2004 Plan by 2,000,000 shares, from 19,150,000 to 21,150,000 shares; (b) eliminate the requirement that certain "full value awards" granted to our employees or consultants meet certain minimum vesting conditions; (c) eliminate certain liberal share counting provisions by providing that (1) shares of common stock repurchased on the open market with option exercise proceeds will not be available again for grant under the Amended 2004 Plan, and (2) the full number of shares underlying a stock-settled stock appreciation right, or SAR, will not be available again for grant under the Amended 2004 Plan; (d) provide that from and after the date of the Annual Meeting, full value awards will be counted as 1.5 shares, rather than 1.4 shares; (e) manage our share usage by prohibiting the payment or grant of dividends and dividend equivalents with respect to options or SARs subject to performance-based vesting; and (f) better align pay-for-performance practices by providing that no dividend equivalents will be paid with respect to performance-based awards until such awards vest.

Under the 2004 Plan, a total of 21,150,000 shares of Medivation common stock, including shares previously issued and shares subject to currently outstanding awards, may be issued pursuant to grants of equity awards. Equity awards may be in the form of stock options, stock appreciation rights, restricted stock units, dividend equivalents, stock payments, performance shares, performance-based awards or any combination thereof. Equity awards may be issued to employees, officers, executive officers and consultants and of Medivation and its subsidiaries.

A more detailed description of the 2004 Plan is set forth under the heading "Proposal No. 4 Approval of the Medivation, Inc. Amended and Restated 2004 Equity Incentive Plan" in the Company's definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 30, 2014 (the "Proxy Statement"). The foregoing description of the 2004 Plan is not purported to be complete, and is qualified by reference to the complete 2004 Plan, which is filed as Exhibit 10.1 hereto and incorporated by reference herein.




Item 5.07. Submission of Matters to a Vote of Security Holders.

The Annual Meeting was held on June 27, 2014, and four proposals were submitted to the Medivation stockholders for a vote. The final votes on the proposals presented at the Annual Meeting, each of which is described in more detail in the Proxy Statement, were as follows:

Proposal 1:

Daniel D. Adams, Kim D. Blickenstaff, Kathryn E. Falberg, David T. Hung, M.D.,
C. Patrick Machado, Dawn Svoronos, W. Anthony Vernon and Wendy L. Yarno were
elected as directors, to hold office until Medivation's next annual meeting of
stockholders, by the following vote:



        Name of Nominee           For           Withheld        Broker Non-Votes
        Daniel D. Adams         60,530,301       1,090,764              5,895,580
        Kim D. Blickenstaff     60,557,802       1,063,263              5,895,580
        Kathryn E. Falberg      60,535,489       1,085,576              5,895,580
        David T. Hung, M.D.     60,555,884       1,065,181              5,895,580
        C. Patrick Machado      61,245,896         375,169              5,895,580
        Dawn Svoronos           60,541,983       1,079,082              5,895,580
        W. Anthony Vernon       60,542,117       1,078,948              5,895,580
        Wendy L. Yarno          60,540,842       1,080,223              5,895,580

Proposal 2:

The selection by the Audit Committee of the Board of PricewaterhouseCoopers LLP as Medivation's independent registered public accounting firm for the fiscal year ending December 31, 2014, was ratified by the following vote:

For Against Abstain Broker Non-Votes 67,378,985 49,120 88,540 -

Proposal 3:

The compensation of Medivation's named executive officers as disclosed in the Proxy Statement was approved, on an advisory basis, by the following vote:

For Against Abstain Broker Non-Votes 61,136,693 282,180 202,191 5,895,581

Proposal 4:

The Medivation, Inc. Amended and Restated 2004 Equity Incentive Award Plan was approved by the following vote:

For Against Abstain Broker Non-Votes 48,299,904 13,197,282 123,879 5,895,580




Item 9.01. Financial Statements and Exhibits

(d) Exhibits:

10.1 The Medivation, Inc. Amended and Restated 2004 Equity Incentive Award Plan.


  Add MDVN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MDVN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.